Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07141862

Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

In prepubertal patients, cryopreservation of ovarian or testicular tissue is currently the only available method for fertility preservation prior to gonadotoxic cancer treatments. However, this approach carries the risk of reintroducing malignant cells upon autotransplantation, particularly in cases of metastatic cancers such as neuroblastoma and Ewing sarcoma. Therefore, it is crucial to employ highly sensitive techniques to detect minimal residual disease (MRD) in preserved gonadal tissues. This study aims to identify the most effective detection method by comparing the sensitivity and specificity of reverse transcription quantitative PCR (RT-qPCR) and droplet digital PCR (ddPCR) in identifying MRD of neuroblastoma and Ewing sarcoma in ovarian and testicular tissues from patients treated for these malignancies during infancy.

Official title: Fertility Preservation in Children With Neuroblastoma or Ewing's Sarcoma: Detection of Residual Disease by a Sensitive Method

Key Details

Gender

All

Age Range

2 Years - 45 Years

Study Type

OBSERVATIONAL

Enrollment

89

Start Date

2025-02-01

Completion Date

2027-12-31

Last Updated

2025-09-03

Healthy Volunteers

Not specified

Interventions

DIAGNOSTIC_TEST

RT-qPCR

Detection of MRD of neuroblastoma and Ewing sarcoma in ovarian and testicular tissues using RT-qPCR

DIAGNOSTIC_TEST

ddPCR

Detection of MRD of neuroblastoma and Ewing sarcoma in ovarian and testicular tissues using ddPCR

Locations (1)

University hospital

Clermont-Ferrand, Auvergne, France